Presenting Inicure at the pitching final at the European AMR conference in Basel 25-26 February 2025 (at minute 17′ in the you tube video) for partners, collaborators and future investors.
Pitching final at the AMR conference Basel
GoWest 29-30 January
Looking forward to meet research partners and investors at the GoWest – Nordic capital forum 29-30 January.
Functional selective FPR1 signaling in favor of an activationof the neutrophil superoxide generating NOX2 complex
Inicure lead compound characterised as a specific agonist for FPR1, which displays a biased signalling profile that leads to a functional selective activating of the human neutrophils class (https://doi.org/10.1002/JLB.2HI0520-317R).